Cel-Sci - 53 Year Dividend History | CVM
Historical dividend payout and yield for Cel-Sci (CVM) since 1971. The current TTM dividend payout for Cel-Sci (CVM) as of April 23, 2024 is $0.00. The current dividend yield for Cel-Sci as of April 23, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.082B |
$0.000B |
|
CEL-SCI CORP. was formed to acquire and finance research and development of natural human interleukin-2 (``IL-2``) and lymphokine-related products and processes using the Co.'s proprietary cell culture technologies. The Co.'s proprietary product is sometimes referred to as MULTIKINEn, or buffy-coat interleukins, which is a combination, or ``cocktail`` of IL-2 and certain lymphokines and cytokines. MULTIKINE is a trade name of Co. Since its inception the focus of the Co.'s product development efforts has been on conducting clinical trials to test its proprietary technologies.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
